CAF-derived CXCL12 enhances the immune evasion of bladder cancer by inhibiting P62-mediated autophagic degradation of PD-L1, thereby promoting the growth of bladder cancer cells (51). The gene discussed is CXCL12; the disease is urinary bladder carcinoma.